VACCINE

Nov 02 2024POLITICS

Trump Ally Wants Vaccine Data to Prove Safety Concerns

A key figure in Donald Trump's transition team has revealed that Robert F. Kennedy Jr. , a prominent vaccine skeptic, wants access to federal health data. Kennedy believes this data will help him prove that vaccines are unsafe, potentially leading to their removal from the market if Trump returns to

reading time less than a minute
Nov 02 2024POLITICS

Trump Ally Wants Vaccine Data To Prove They’re Unsafe

Robert F. Kennedy Jr. , a prominent Trump supporter, is eyeing federal health data to show that vaccines are unsafe. This was revealed by Howard Lutnick, a co-chair of Donald Trump's transition team, during a recent CNN interview. Lutnick echoed Kennedy's controversial views about vaccines, includin

reading time less than a minute
Nov 02 2024POLITICS

What If Trump Picks an Anti-Vaxxer for Health Secretary?

In the final stretch of the presidential campaign, candidates often push their concluding messages to capture undecided voters. Kamala Harris made her pitch on Tuesday, contrasting herself with Donald Trump. While Harris aims to be a regular Democrat president, Trump has other plans. The Trump campa

reading time less than a minute
Nov 01 2024HEALTH

COVID Vaccines Banned: A Unique Decision in Idaho

In a surprising move, a public health department in Idaho has been barred from giving COVID-19 vaccines. This is the first time in the US that a health department has been halted from providing these vital shots. While other states have limited vaccine promotion or recommended against them, Idaho's

reading time less than a minute
Nov 01 2024POLITICS

Vaccine Skeptics in Trump's Transition Team: A Public Health Worry

A few days ago, Robert F. Kennedy Jr. shared on a Zoom call that President Trump had promised him a top job at the Department of Health and Human Services (HHS), the agency that includes the CDC, FDA, NIH, and USDA. This could be a big problem because Kennedy is known for his anti-vaccine beliefs an

reading time less than a minute
Oct 30 2024BUSINESS

Pfizer's Surprising Q3 Win: Paxlovid and Vaccines Boost Sales

Pfizer recently shared impressive Q3 results that overshot expectations, thanks to its Covid vaccine and antiviral pill, Paxlovid. The drug giant raised its earnings and revenue projections for the year. Despite the positive news, shares dropped by over 2%. Pfizer's CEO, Albert Bourla, is under pres

reading time less than a minute
Oct 27 2024HEALTH

Older Adults and Immunocompromised Advised to Get Extra COVID Shots

The Centers for Disease Control and Prevention (CDC) has some new advice for older adults and people with weakened immune systems. It’s all about getting an extra dose of the COVID-19 vaccine to stay safe. If you’re 65 or older, or if your immune system isn’t as strong, the CDC says to get a second

reading time less than a minute
Oct 26 2024HEALTH

Students' Vaccine Clinic Halted Due to OHIP's Budget Cuts

A planned drive-through vaccine clinic by the Frontenac Doctors was abruptly cancelled. Why? The Ontario Health Insurance Plan (OHIP) refused to cover the costs. This isn't the first time OHIP's budget cuts have caused trouble, according to a local doctor. The clinic, organized by medical students,

reading time less than a minute
Oct 24 2024HEALTH

Vaccine Against Pneumonia: A New Recommendation for Older Adults

Did you know that the Centers for Disease Control and Prevention (CDC) has recently recommended that adults aged 50 and above should get a shot to protect against pneumococcal disease? This decision was made by a scientific panel and then approved by the CDC. This disease is caused by a type of bact

reading time less than a minute
Oct 18 2024BUSINESS

Biotech Moves: Layoffs, Deals, and Drug Concerns

Let's take a look at what's been happening in the biotech world today. Sage Therapeutics is cutting its workforce by a third and changing its leadership. Why? Recent clinical trial failures have likely played a role. Over in Australia, regulators have rejected Eisai and Biogen's Alzheimer's drug, L

reading time less than a minute